Pancreatic Cancer Research

Journal articleTheranostics2022

Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer.

Journal
Theranostics
Published
1 January 2022
Citations
28
Type
Article
License
cc by
Full text
Open access, reuse-licensed (cc by)

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.

Try